search
Back to results

Fascia Iliaca Compartment Blocks for Pain Control in Hip Fractures

Primary Purpose

Hip Fractures

Status
Withdrawn
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
Nerve Block
Sponsored by
Medical University of South Carolina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hip Fractures

Eligibility Criteria

50 Years - 100 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Aged 50 or older, low energy hip fracture, acute hip fracture

Exclusion Criteria:

  • On anticoagulants, hardware present near injection site, preexisting nerve injury.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    Non nerve block

    Nerve block

    Arm Description

    Receives no nerve block

    Receives nerve block

    Outcomes

    Primary Outcome Measures

    Mean Baseline Pain score on Visual analogue scale at initial encounter
    pain is measured 1-10, 1 being the lowest and 10 being the highest
    Mean Change from baseline pain score on the visual analogue scale
    pain is measured 1-10, 1 being the lowest and 10 being the highest

    Secondary Outcome Measures

    Full Information

    First Posted
    September 10, 2019
    Last Updated
    February 4, 2020
    Sponsor
    Medical University of South Carolina
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04086914
    Brief Title
    Fascia Iliaca Compartment Blocks for Pain Control in Hip Fractures
    Official Title
    Fascia Iliaca Compartment Blocks to Improve Preoperative Pain Control in Elderly Hip Fractures
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2020
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Study withdrawn at PI's request. no patients enrolled.
    Study Start Date
    February 1, 2020 (Anticipated)
    Primary Completion Date
    November 1, 2020 (Anticipated)
    Study Completion Date
    December 1, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Medical University of South Carolina

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    Yes
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study is comparing the use of a peripheral nerve block and standard opioid pain medications in pain control in hip fractures prior to surgery. A peripheral nerve block is a procedure that injects numbing medicine around a nerve to help decrease the pain, motion, and sensation around the painful site temporarily. The purpose of this study is to evaluate if peripheral nerve blocks are more effective for pain control than just standard opioid pain medication while decreasing the amount of side effects from opioid medication.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hip Fractures

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Early Phase 1
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Non nerve block
    Arm Type
    No Intervention
    Arm Description
    Receives no nerve block
    Arm Title
    Nerve block
    Arm Type
    Experimental
    Arm Description
    Receives nerve block
    Intervention Type
    Procedure
    Intervention Name(s)
    Nerve Block
    Intervention Description
    This group will receive a nerve block consisting of 20mL of 5mg/mL ropivicanine and 0.1mL of 10mg'mL dexamethasone.
    Primary Outcome Measure Information:
    Title
    Mean Baseline Pain score on Visual analogue scale at initial encounter
    Description
    pain is measured 1-10, 1 being the lowest and 10 being the highest
    Time Frame
    0-60 minutes
    Title
    Mean Change from baseline pain score on the visual analogue scale
    Description
    pain is measured 1-10, 1 being the lowest and 10 being the highest
    Time Frame
    3-8 hours after initial encounter

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    50 Years
    Maximum Age & Unit of Time
    100 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Aged 50 or older, low energy hip fracture, acute hip fracture Exclusion Criteria: On anticoagulants, hardware present near injection site, preexisting nerve injury.

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    33238043
    Citation
    Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.
    Results Reference
    derived

    Learn more about this trial

    Fascia Iliaca Compartment Blocks for Pain Control in Hip Fractures

    We'll reach out to this number within 24 hrs